Trevena, Inc. Appoints Francois Nader, MD, To Its Board Of Directors

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today that Francois Nader, MD, president and chief executive officer of NPS Pharmaceuticals, Inc. has joined its Board of Directors. Dr. Nader is an industry leader with over 30 years of experience in the healthcare sector.

Help employers find you! Check out all the jobs and post your resume.